Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Methylprednisolone

Pulmonary infarction aggravation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Hijikata Y, et al. Kampo medicines improved blood test and QOL in two vasculitis cases of Churg-Strauss syndrome and Henoch-Shonlein purpura after inadequate treatment with conventional therapies. International Journal of General Medicine 3: 93-99, Jan 2010 - JapanCrossRefPubMedCentralPubMed Hijikata Y, et al. Kampo medicines improved blood test and QOL in two vasculitis cases of Churg-Strauss syndrome and Henoch-Shonlein purpura after inadequate treatment with conventional therapies. International Journal of General Medicine 3: 93-99, Jan 2010 - JapanCrossRefPubMedCentralPubMed
Metadaten
Titel
Methylprednisolone
Pulmonary infarction aggravation: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9999-9

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Fosphenytoin

Case report

Hydrocortisone